178 related articles for article (PubMed ID: 30271737)
1. Hepatitis C Virus Clearance by Direct-acting Antiviral Results in Rapid Resolution of Hepatocytic Injury as Indicated by Both Alanine Aminotransferase and Aspartate Aminotransferase Normalization.
Huynh T; Zhang J; Hu KQ
J Clin Transl Hepatol; 2018 Sep; 6(3):258-263. PubMed ID: 30271737
[No Abstract] [Full Text] [Related]
2. HCV direct acting antiviral treatment leads to highly durable rates of ALT and AST lower than 30/19 criteria and improved APRI and FIB-4 scores.
Huynh T; Ma S; Hu KQ
Hepatol Commun; 2022 Dec; 6(12):3496-3504. PubMed ID: 36221305
[TBL] [Abstract][Full Text] [Related]
3. Soluble Markers of Immune Activation Differentially Normalize and Selectively Associate with Improvement in AST, ALT, Albumin, and Transient Elastography During IFN-Free HCV Therapy.
Kostadinova L; Shive CL; Zebrowski E; Fuller B; Rife K; Hirsch A; Compan A; Moreland A; Falck-Ytter Y; Popkin DL; Anthony DD
Pathog Immun; 2018 Sep; 3(1):149-163. PubMed ID: 30370392
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders.
Lok AS; Gardiner DF; Hézode C; Lawitz EJ; Bourlière M; Everson GT; Marcellin P; Rodriguez-Torres M; Pol S; Serfaty L; Eley T; Huang SP; Li J; Wind-Rotolo M; Yu F; McPhee F; Grasela DM; Pasquinelli C
J Hepatol; 2014 Mar; 60(3):490-9. PubMed ID: 24444658
[TBL] [Abstract][Full Text] [Related]
5. Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis.
Fabrizi F; Lunghi G; Finazzi S; Colucci P; Pagano A; Ponticelli C; Locatelli F
Am J Kidney Dis; 2001 Nov; 38(5):1009-15. PubMed ID: 11684554
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV.
Liu CJ; Chuang WL; Sheen IS; Wang HY; Chen CY; Tseng KC; Chang TT; Massetto B; Yang JC; Yun C; Knox SJ; Osinusi A; Camus G; Jiang D; Brainard DM; McHutchison JG; Hu TH; Hsu YC; Lo GH; Chu CJ; Chen JJ; Peng CY; Chien RN; Chen PJ
Gastroenterology; 2018 Mar; 154(4):989-997. PubMed ID: 29174546
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for remaining liver injury in patients with virological elimination of chronic hepatitis C.
Mauss S; Buendgens L; Christensen S; Ingiliz P; Berger F; Hüppe D; Simon KG; Lutz T; Schewe K; Boesecke C; Tacke F
Z Gastroenterol; 2019 Feb; 57(2):139-147. PubMed ID: 30754058
[TBL] [Abstract][Full Text] [Related]
8. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease.
Giannini E; Risso D; Botta F; Chiarbonello B; Fasoli A; Malfatti F; Romagnoli P; Testa E; Ceppa P; Testa R
Arch Intern Med; 2003 Jan; 163(2):218-24. PubMed ID: 12546613
[TBL] [Abstract][Full Text] [Related]
9. Quantification of Core Antigen Monitors Efficacy of Direct-acting Antiviral Agents in Patients With Chronic Hepatitis C Virus Infection.
Aghemo A; Degasperi E; De Nicola S; Bono P; Orlandi A; D'Ambrosio R; Soffredini R; Perbellini R; Lunghi G; Colombo M
Clin Gastroenterol Hepatol; 2016 Sep; 14(9):1331-6. PubMed ID: 27046484
[TBL] [Abstract][Full Text] [Related]
10. Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy.
Liang CC; Liu CH; Chung CS; Lin CK; Su TH; Yang HC; Liu CJ; Chen PJ; Chen DS; Kao JH
J Infect Dis; 2015 May; 211(9):1429-36. PubMed ID: 25387585
[TBL] [Abstract][Full Text] [Related]
11. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
Farrell GC; Bacon BR; Goldin RD
Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
[TBL] [Abstract][Full Text] [Related]
12. A retrospective pilot study to examine the potential of aspartate aminotransferase to alanine aminotransferase ratio as a predictor of postoperative acute kidney injury in patients with hepatocellular carcinoma.
Xu J; Xia Y; Li S; Cheng X; Hu S; Gao Y; Zhou X; Wang G; Zheng Q
Ann Clin Biochem; 2019 May; 56(3):357-366. PubMed ID: 30453754
[TBL] [Abstract][Full Text] [Related]
13. Clinical presentation, outcome, and response to therapy among patients with acute exacerbation of chronic hepatitis C.
Sagnelli E; Pisaturo M; Stanzione M; Messina V; Alessio L; Sagnelli C; Starace M; Pasquale G; Coppola N
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1174-1180.e11. PubMed ID: 23591280
[TBL] [Abstract][Full Text] [Related]
14. Revised cutoff values of serum aminotransferase in detecting viral hepatitis among CAPD patients: experience from Taiwan, an endemic area for hepatitis B.
Hung KY; Lee KC; Yen CJ; Wu KD; Tsai TJ; Chen WY
Nephrol Dial Transplant; 1997 Jan; 12(1):180-3. PubMed ID: 9157333
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of
Świątek-Kościelna B; Kałużna E; Strauss E; Nowak J; Bereszyńska I; Gowin E; Wysocki J; Rembowska J; Barcińska D; Mozer-Lisewska I; Januszkiewicz-Lewandowska D
World J Gastroenterol; 2017 Jun; 23(21):3815-3824. PubMed ID: 28638221
[TBL] [Abstract][Full Text] [Related]
16. Influence of hepatitis C virus (HCV) viraemia upon serum aminotransferase activity in chronic dialysis patients.
Fabrizi F; Lunghi G; Andrulli S; Pagliari B; Mangano S; Faranna P; Pagano A; Locatelli F
Nephrol Dial Transplant; 1997 Jul; 12(7):1394-8. PubMed ID: 9249775
[TBL] [Abstract][Full Text] [Related]
17. Sustained virological response rates to antiviral therapy in genotype 1 and 3 chronic hepatitis C patients: a study from north India.
Gupta V; Kumar A; Sharma P; Tyagi P; Bansal N; Singla V; Arora A
J Clin Exp Hepatol; 2014 Dec; 4(4):287-92. PubMed ID: 25755575
[TBL] [Abstract][Full Text] [Related]
18. Correlation of serum aminotransferases with HCV RNA levels and histological findings in patients with chronic hepatitis C: the role of serum aspartate transaminase in the evaluation of disease progression.
Zechini B; Pasquazzi C; Aceti A
Eur J Gastroenterol Hepatol; 2004 Sep; 16(9):891-6. PubMed ID: 15316414
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Sofosbuvir and Ribavirin for Treating Chronic Hepatitis C, Genotype 3: Experience of a Tertiary Care Hospital at Karachi, Pakistan.
Butt N; Reema S; Ali Khan M; Abbasi A; Butt S; Khoso MM; Akbar A; Haleem F; Mahesar GB; Fahad A; Qureshi T
Cureus; 2019 Apr; 11(4):e4458. PubMed ID: 31205844
[TBL] [Abstract][Full Text] [Related]
20. Is delayed normalization of alanine aminotransferase a poor prognostic predictor in chronic hepatitis C patients treated with a combined interferon and ribavirin therapy?
Hung CH; Lee CM; Lu SN; Wang JH; Tung HD; Chen TM; Chen CH; Changchien CS
J Gastroenterol Hepatol; 2002 Dec; 17(12):1307-11. PubMed ID: 12423276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
